Skip to main content
. 2015 Aug 4;34:501–508. doi: 10.1007/s00345-015-1650-0

Table 3.

Pathology outcomes

Overall Group 1 Group 2 p value
Target cores positive 158/228 (69.3 %) 76/106 (71.7 %) 82/122 (67.2 %) 0.476
Background cores positive 344/1881 (18.38 %) 101/876 (11.5 %) 243/1005 (24.2 %) <0.001
Core mean length: range (median) 5.6–14.7 (10.35) 5.6–14.7 (10.15) 6.5–14.5 (10.5) 0.555
Final Gleason grade (n = 76) (n = 41) (n = 48) 0.122
3 + 3 9 (11.8 %) 8 (9 %) 3 (3.4 %)
3 + 4 32 (42.1 %) 21 (23.6 %) 19 (21.3 %)
4 + 3 14 (18.4 %) 4 (4.5 %) 12 (13.4 %)
8 5 (6.6 %) 3 (3.4 %) 3 (3.4 %)
9 15 (19.7 %) 5 (5.6 %) 10 (11.2 %)
10 1 (1.4 %) 0 (0 %) 1 (1.1 %)

Group 1: target biopsy cores show higher Gleason grade; Group 2: target sector biopsy cores show equal or higher Gleason grade. Overall “final Gleason grade” listed as highest Gleason score per patient